Related Experiment Video
Updated: Oct 5, 2025
06:22
Optical Sectioning and Visualization of the Intervertebral Disc from Embryonic Development to Degeneration
Published on: July 8, 2021
2.3K
Extracellular Vesicles Derived From Stem Cells in Intervertebral Disc Degeneration
1Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China.
Frontiers in Cell and Developmental Biology
|January 31, 2022
Summary
Stem cell-derived extracellular vesicles (SC-EVs) show promise for treating intervertebral disc degeneration (IVDD), a common cause of low back pain. These vesicles can promote tissue regeneration and alleviate cell death, offering new therapeutic avenues.
Area of Science:
- Regenerative Medicine
- Biotechnology
- Orthopedics
Background:
- Intervertebral disc degeneration (IVDD) is a primary cause of low back pain, characterized by tissue degradation due to oxidative stress and apoptosis.
- Extracellular vesicles (EVs), particularly those derived from stem cells (SC-EVs), are key paracrine mediators with significant therapeutic potential.
- SC-EVs are emerging as a novel therapeutic strategy for IVDD, with roles in tissue regeneration and disease modulation.
Purpose of the Study:
- To provide a comprehensive overview of SC-EVs in the context of IVDD.
- To discuss the therapeutic and diagnostic potential of SC-EVs for IVDD.
- To explore the mechanisms by which SC-EVs exert their effects in IVDD.
Main Methods:
- Literature review of studies on SC-EVs and IVDD.
- Analysis of the mechanisms of SC-EV action, including regenerative phenotypes, apoptosis, and immune modulation.
- Discussion of strategies to enhance SC-EV therapeutic efficacy.
Main Results:
- SC-EVs demonstrate therapeutic potential by inducing regenerative phenotypes in degenerated discs.
- SC-EVs can alleviate cell apoptosis and modulate immune responses within the disc microenvironment.
- Optimizing donor cells, culture conditions, and EV engineering can enhance SC-EV therapeutic efficiency.
Conclusions:
- SC-EVs represent a promising cell-free therapeutic approach for managing IVDD.
- Further research into SC-EVs could lead to novel diagnostic and regenerative strategies for low back pain.
- Enhancing SC-EV properties holds potential for improving treatment outcomes in IVDD.
Related Concept Videos
01:36Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
01:19Mesenchymal Stem Cells
5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
01:38Intralumenal Vesicles and Multivesicular Bodies
3.8K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.8K
00:57Embryonic Stem Cells
3.8K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.8K